Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Company Deals

Star Sports Medicine Raises HKD 830 Million in Hong Kong IPO as China’s Leading Domestic Sports Medicine Provider

Fineline Cube Apr 24, 2026
Company Deals

Sisram Medical Forges Strategic Alliance for Daxxify Commercialization in China’s Long-Acting Botulinum Toxin Market

Fineline Cube Apr 24, 2026
Company Deals Digital

SciClone Pharmaceuticals Partners with JD Healthcare to Pioneer Integrated Immune Health Management Model

Fineline Cube Apr 24, 2026
Company Deals

Mebanks Divests Guangzhou Specialty Pharmacy Subsidiary to DaShenLin for $7.75 Million to Focus on Higher-Margin Health Insurance and Management Businesses

Fineline Cube Apr 23, 2026
Company Deals

AbbVie Announces $1.4 Billion Advanced Manufacturing Campus in North Carolina to Support Immunology, Neuroscience, and Oncology Portfolio

Fineline Cube Apr 23, 2026
Policy / Regulatory

NMPA Suspends Colchicine API Imports from Indian Manufacturers Alkaloids Bioactives and Alchem International Over Change Management Violations

Fineline Cube Apr 23, 2026
Company Drug

China Medical System’s Comekibart Anti-IL-4Rα Antibody Enters NMPA Review for Seasonal Allergic Rhinitis

Fineline Cube Apr 24, 2026
Company Drug

AbbVie Receives FDA Complete Response Letter for TrenibotE with Manufacturing Clarifications Requested

Fineline Cube Apr 24, 2026
Policy / Regulatory

China’s NMPA Updates Rules for Administrative Penalty Discretions in Drug Supervision

Fineline Cube Feb 27, 2024

The National Medical Products Administration (NMPA) has issued the “Rules for the Application of Administrative...

Company Drug

AstraZeneca’s Fasenra Matches Nucala in EGPA Trial and Shows Steroid Reduction Benefits

Fineline Cube Feb 27, 2024

UK pharmaceutical giant AstraZeneca (AZ; NASDAQ: AZN) has presented results from a Phase III trial...

Company Drug

BeiGene’s Tislelizumab Receives CHMP Recommendation for Three NSCLC Indications in Europe

Fineline Cube Feb 27, 2024

BeiGene (NASDAQ: BGNE) has announced that the European Medicines Agency’s Committee for Medicinal Products for...

Company Deals

Shanghai Fosun Pharmaceutical Partners with Nanning City to Broaden Collaboration in Biopharma and Beyond

Fineline Cube Feb 27, 2024

Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196,HKG: 2196), a Chinese pharmaceutical heavyweight, has entered...

Company Drug

Everest Medicines Gets CDE Approval for Global Phase IIb Study of Zetomipzomib in Lupus Nephritis

Fineline Cube Feb 27, 2024

Everest Medicines (HKG: 1952), a China-based pharmaceutical company, has announced that it has received approval...

Company Drug

Alvotech Scores FDA Nod for Interchangeable High-Concentration Biosimilar to Humira

Fineline Cube Feb 27, 2024

The US Food and Drug Administration (FDA) has granted approval to Iceland-based Alvotech’s (NASDAQ: ALVO)...

Company

BeiGene Reports Record Revenues and Rapid Growth in Q4 and Full Year 2023 with Continued Expansion

Fineline Cube Feb 27, 2024

BeiGene (NASDAQ: BGNE), a China-based biopharmaceutical company, has presented its financial results for the fourth...

Company Deals

Novo Nordisk Partners with Neomorph to Target Undruggable Diseases with Molecular Glue Degraders

Fineline Cube Feb 27, 2024

Danish pharmaceutical giant Novo Nordisk (CPH: NOVO-B) has entered into a partnership with US-based Neomorph...

Company

AstraZeneca Expands Global Footprint with Shanghai Strategic Center

Fineline Cube Feb 27, 2024

AstraZeneca (AZ, NASDAQ: AZN) has declared that Shanghai is now its fifth global strategic center,...

Company Deals

Simcere Pharmaceutical’s Oncology Unit Raises RMB 970 Million to Advance Cancer Drug Development

Fineline Cube Feb 26, 2024

Simcere Pharmaceutical Group (HKG: 2096) has announced that its oncology subsidiary, Simcere Zaiming Pharmaceutical Co.,...

Company Deals Drug

Kelun-Biotech Launches Clinical Trials for SKB264, Triggering $75 Million Milestone Payment from MSD

Fineline Cube Feb 26, 2024

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG: 6990) has announced the initiation of clinical trials for...

Company Drug

AstraZeneca Launches Phase I Trial for siRNA Therapy in Collaboration with Silence Therapeutics

Fineline Cube Feb 26, 2024

AstraZeneca (AZ; NASDAQ: AZN) has commenced a Phase I trial for a short interfering RNA...

Company Deals

b-ONE Ortho Partners with THINK Surgical to Expand MOBIO Knee System in U.S. Market

Fineline Cube Feb 26, 2024

b-ONE Ortho Corp., a developer of artificial joint replacements with operations in the U.S. and...

Company Deals

CardioACC Initiates Regulatory Study for Groundbreaking 7.5F Intracardiac Ultrasound System

Fineline Cube Feb 26, 2024

CardioACC, a Shenzhen-based company specializing in cardiovascular interventional imaging and treatment technologies, has launched a...

Company Deals

Jiangsu Nhwa Secures Exclusive Rights to Teva’s Austedo in China with $30 Million Deal

Fineline Cube Feb 26, 2024

Jiangsu Nhwa Pharmaceutical Co., Ltd. (SHE: 002262), based in China, has entered into a cooperation...

Policy / Regulatory

Guangdong Province Releases New Batch of Urgently Needed Drugs and Medical Devices for Greater Bay Area

Fineline Cube Feb 26, 2024

The Medical Products Administration and Health Commission of Guangdong province have released the sixth batch...

Company Deals Digital

Tencent Hands Over Two Former CSIG Employees to Authorities on Embezzlement Allegations

Fineline Cube Feb 26, 2024

Chinese internet conglomerate Tencent has announced via its anti-fraud department’s official channel that former employees...

Company Drug

Sanofi’s Dupixent Receives FDA Priority Review for COPD Indication Extension

Fineline Cube Feb 26, 2024

Sanofi (NASDAQ: SNY), a French multinational pharmaceutical company, announced last week that the US Food...

Company Deals

Kexing Pharmaceutical Partners with Yabao to Distribute Generic Nexavar in Ten Countries

Fineline Cube Feb 26, 2024

China-based Kexing Pharmaceutical (SHA: 688136) has entered into an overseas cooperation agreement with fellow domestic...

Policy / Regulatory

Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits

Fineline Cube Feb 26, 2024

The Fujian provincial health commission and medical products administration have jointly issued the “Provisional Regulations...

Posts pagination

1 … 388 389 390 … 656

Recent updates

  • Insilico Medicine Advances AI-Designed PRMT5 Inhibitor ISM0387 for Glioblastoma with Sub-12-Month Discovery Timeline
  • Star Sports Medicine Raises HKD 830 Million in Hong Kong IPO as China’s Leading Domestic Sports Medicine Provider
  • Huadong Medicine Secures NMPA Approval for Ellansé M PCL Microsphere Filler for Temple Hollowing Correction
  • Sisram Medical Forges Strategic Alliance for Daxxify Commercialization in China’s Long-Acting Botulinum Toxin Market
  • China Medical System’s Comekibart Anti-IL-4Rα Antibody Enters NMPA Review for Seasonal Allergic Rhinitis
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company R&D

Insilico Medicine Advances AI-Designed PRMT5 Inhibitor ISM0387 for Glioblastoma with Sub-12-Month Discovery Timeline

Company Deals

Star Sports Medicine Raises HKD 830 Million in Hong Kong IPO as China’s Leading Domestic Sports Medicine Provider

Company Medical Device

Huadong Medicine Secures NMPA Approval for Ellansé M PCL Microsphere Filler for Temple Hollowing Correction

Company Deals

Sisram Medical Forges Strategic Alliance for Daxxify Commercialization in China’s Long-Acting Botulinum Toxin Market

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.